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Although no specific operation can truly be considered the "gold standard," sacral colpopexy appears to be the most successful vaginal vault suspension operation. 1, 2 Even though multiple long-term colpopexy studies cite prolapse cure rates of between 84% and 99%, [2] [3] [4] there is no such study that includes long-term results measured with objective prolapse assessment and validated qualityof-life measures.
Regardless of the surgical approach, the recovery period after reconstructive pelvic surgery involves significant morbidity, so informed consent for these operations should include the best possible information regarding long-term results for prolapse correction and symptom relief. Regrettably, there are few scientific data to draw on when counseling patients about the long-term subjective and objective cure rates after prolapse surgery.
There are several reasons for this lack of long-term information. Until recently, there were no standardized assessment tools with which to measure the success of prolapse surgery. With the publication of the International Continence Society system for pelvic organ prolapse quantification (the POP-Q system) in 1996, widespread standardized, objective reporting of prolapse was made possible for the first time. 5 Many groups are now working to validate prolapse symptom assessment tools as well. Current and future studies regarding prolapse surgery should include both objective outcomes measured with the POP-Q system as well as symptom relief and prolapse-related quality of life scores measured with reliable, validated instruments. 6 But the availability of these research tools does not guarantee that patients will return for long-term followup. It is generally believed that clinical trials regarding these operations should be designed to include at least 5 years of follow-up because durability of pelvic reconstructive surgery deteriorates over time. 7 However, others have argued that short-term follow-up may provide useful information. Shull et al 8 found that patients with normal support during an early postoperative visit were unlikely to have subsequent failures.
When patients fail to return for long-term follow-up in any surgical study regarding prolapse, there is always the question: did they fail to come back because they were better, or because they had experienced a failure? In other words, to what extent did selection bias influence the study results?
The objective of this study was to establish the natural history of sacral colpopexy procedures performed with synthetic mesh. Our specific aim was to determine the minimum meaningful study period required for prospective trials including sacral colpopexy by controlling for selection bias.
Material and methods

Study design.
A retrospective analysis was performed including all patients (n = 245) undergoing abdominal sacral colpopexy with synthetic mesh performed by members of the University of Louisville Health Sciences Center Division of Urogynecology and Reconstructive Pelvic Surgery. The operations were performed between September 11, 1994, and January 1, 2001. The surgical cases were identified by a combined review of our surgery schedule logs and hospital records. The University of Louisville Human Studies Committee approved the review and analysis of these records.
Operative technique. With the patient in Allen universal stirrups (Allen Medical Systems, Bedford Heights, Ohio), the prolapsed vaginal wall was replaced with an acrylic vaginal stent. The sigmoid colon was retracted laterally to the left pelvic sidewall, as the peritoneum of the right paracolic gutter was incised from sacral promontory to cul-de-sac. Sharp and blunt dissection was used to expose the anterior longitudinal ligament at the S2 to S3 level, and two to four permanent sutures were placed. Concomitant hysterectomy or salpingo-oophorectomy were performed before the sacral dissection when indicated. The vesicovaginal space was entered sharply, and the mesh was attached to the anterior vaginal wall with six to eight permanent sutures. A second piece of mesh was attached to the posterior vaginal wall with three to six rows of permanent sutures. The anterior mesh was then attached to the posterior mesh, which was then fastened to the sacral sutures without applying tension to the vaginal attachments. The peritoneum was then reapproximated over the mesh, and any other concomitant procedures were performed as indicated. Intraoperative cystoscopy was performed on all patients to assess ureteral function.
Outcome measures. Preoperative evaluations of these patients included urogynecologic history and physical examinations as previously described. 9 Pelvic organ prolapse was assessed according to the International Continence Society's POP-Q system. All patients underwent prolapse assessment in both the supine and standing position while performing a maximum Valsalva maneuver. All patients also underwent multichannel urodynamic studies with concomitant support of their prolapse, including retrograde cystometry, urethral pressure profilometry, cough and Valsalva leak point pressure assessment, voiding pressure studies, uroflowometry, and postvoid residual assessment. Methods, definitions, and descriptions conform to the standards recommended by the International Continence Society. 10 Our standard postoperative follow-up included office visits and POP-Q assessment at 6 weeks, 3 months, 6 months, and yearly thereafter. Charts were reviewed to identify demographics, history, intraoperative, and postoperative events.
POP-Q staging and POP-Q point positions were followed over time as our objective endpoint of interest. Objective failure was defined as POP-Q stage II or greater at any postoperative interval. We controlled for selection bias by comparing responders to nonresponders for preoperative clinical and demographic data, as well as postoperative subjective outcome measures. Responders were defined as those patients who were available for postoperative POP-Q staging at a given postoperative interval. Nonresponders were defined as those patients who were scheduled but not available for postoperative POP-Q staging at a given postoperative visit. A validated prolapse specific quality of life instrument 11 was administered by a telephone survey as our postoperative subjective outcome measure. The University of Louisville Human Studies Committee approved the telephone survey protocol. The PART I: PSI 1. I feel that I have to push or strain to empty the urine from my bladder.
2. I assist my bladder to empty by placing a finger in the vagina or pressing on the skin outside of the vagina. 3. I experience leakage of urine (incontinence) when I engage in activities such as coughing, sneezing, laughing, lifting, walking, or changing position. 4. I rush to the bathroom so I will not leak urine. 5. I wear protection (such as pads, diapers, or toilet paper) or change my undergarments to protect my clothes from urinary leakage. 6. I experience constipation due to difficulty moving the stool out of my rectum. 7. I assist myself to empty my bowels by placing a finger in the vagina. 8. I experience incontinence of stool. 9. I feel as though there is a "ball" between my legs or that I am sitting on a "ball." 10. I feel a pressure in my vagina when standing which may lessen when lying down. 11. Do you need to change positions or posture to help you empty your bladder? PART II: QOL 12. Some or all of the symptoms, which are described above, prevent me from pursuing new relationships with people. 13. Some or all of the symptoms, which are described above, interfere with my sexual relationships. 14. Some or all of the symptoms, which are described above, prevent me from engaging in physical recreation (dancing, sports, etc). 15. Some or all of the symptoms, which are described above, prevent me from engaging in nonstrenuous leisure activities (eating out, going to a show, etc). validated quality of life (QOL) instrument contained 15 questions with five Likert scale options ranging from "never" to "all of the time" that are scored from 0 to 4 ( Table I ). The first 11 questions make up a prolapse specific symptom inventory (PSI), questions 12 to 15 determine QOL score related to those symptoms. Total PSI or QOL scores were calculated by adding the scores for the questions in those sections. Each of the telephone interviews was conducted by one of two independent examiners with no prior relationships to any of the study patients.
We also collected postoperative complications such as erosion of the synthetic mesh through the vaginal wall. Because all mesh erosions are handled in the operating room, the patient charts were compared with our surgical schedule logs to make sure all cases of vaginal mesh erosion were identified. Charts were also reviewed to identify patients who required prolapse or incontinence surgery after the index colpopexy.
Statistical analysis. POP-Q staging and POP-Q point positions were followed over time because of the time-dependent effectiveness of prolapse surgery reported in the medical literature. 12 Life-table analysis that used KaplanMeier statistics were not chosen because they require strict end points (mortality for example). We chose a nonparametric repeated measures analysis (Wilcoxon test) because the exact date of surgical failure is unattainable in most cases. The POP-Q stage and POP-Q point positions at each postoperative visit were compared with preoperative values for this analysis. Mean POP-Q point positions and 95% CIs were calculated to establish the accuracy and magnitude of these differences.
We compared responders with nonresponders for clinical, demographic, and subjective outcome measures with *The patients for whom these measurements were impossible had not reached the postoperative interval. 
Results
During the study period, 245 patients underwent abdominal sacral colpopexy with synthetic mesh through the Division of Urogynecology and Reconstructive Pelvic Surgery. There were 22 patients for whom no preoperative POP-Q measures could be found. We kept these patients in the study group because we had postoperative clinical and demographic information about them. Demographics of the study group are provided in Table II .
In addition to sacral colpopexy, the study group received 11 hysterectomies, 145 paravaginal repairs, 39 posterior repairs, 106 Burch procedures, 48 tension-free vaginal tape procedures, 17 suburethral slings using donor fascia lata, 22 perineorraphies, 47 Halban procedures, and 6 anterior colporraphies. The mean estimated blood loss per patient was 328.5 ± 203.4 mL (range, 50-1300) and two patients required blood transfusions. Intraoperative complications included one cystotomy repaired without sequela and two patients with ureteral obstructions noted and relieved during surgery. Immediate postoperative complications included two small bowel obstructions requiring reoperation, one femoral neuropathy that spontaneously resolved over 3 months, one fascial dehiscence, two deep venous thromboses, and one pulmonary embolism. Table III lists the 23 patients who underwent a repair of graft erosion, a prolapse operation, or a continence operation after the index colpopexy. Six patients (2.4%) had postoperative graft erosion through the vaginal wall. Of the 11 patients who underwent a hysterectomy at the time of their colpopexy, 3 (27.3%) had erosion of graft material, but of the 234 patients who did not have a hysterectomy at the time of their colpopexy, 3 (1.3%) mesh erosions occurred. This difference in mesh erosion rates between the hysterectomy and nonhysterectomy groups was significant (P < .001). Fig 1 shows the preoperative and postoperative POP-Q stages in graphic form with 95% CIs. The graphs for all apical, anterior, and posterior POP-Q points at all postoperative intervals looked very similar to this POP-Q stage graph and were therefore omitted from this report. There were statistically significant improvements in POP-Q stage and all POP-Q data points, except total vaginal length and perineal body measures at all postoperative intervals (P values between .00001 and .012 for all). There were statistically significant differences between preoperative and postoperative vaginal length until the ≥4-year postoperative interval (Fig 2) . Perineal body measurements did not change significantly (Fig 3) . Introitus measurements were significantly smaller at all postoperative intervals (Fig 4) .
Objective failure was defined as any postoperative POP-Q point ≥ stage II. Such failure was found in 37 (15.1%) Yes (n = 147) 62 ± 10 27 ± 5 333 ± 203 2.6 ± 0.6 (P = .71) (P = .45) (P = .67) (P = .82) No (n = 76) 61 ± 12 27 ± 4 321 ± 206 2.5 ± 0.6 6 mo Yes (n = 133) 63 ± 10 26 ± 4 327 ± 201 2.6 ± 0.6 (P = .006) (P = .39) (P = .78) (P = .74) No (n = 90) 59 ± 11 27 ± 4 330 ± 208 2.6 ± 0.5 1 y Yes (n = 118) 63 ± 10 26 ± 4 326 ± 202 2.5 ± 0.6 (P = .03) (P = .30) (P = .62) (P = .80) No (n = 105) 60 ± 12 28 ± 5 340 ± 212 2.6 ± 0.6 2 y Yes (n = 44) 63 ± 10 25 ± 4 336 ± 214 2.5 ± 0.6 (P = .43) (P = .046) (P = .44) (P = .98) No (n = 138) 60 ± 22 28 ± 5 340 ± 211 2.6 ± 0.6 3 y Yes (n = 44) 64 ± 9 26 ± 6 345 ± 242 2.5 ± 0.8 (P = .06) (P = .43) (P = .14) (P = patients. Of these, 26 (70.3%) occurred within 6 months, and 30 (81.1%) were discovered during the first postoperative year. Another 5 objective failures were discovered between 12 and 24 months after surgery, so 94.6% of objective failures occurred within the first 24 months after surgery. Of the objective failures, 22 (57.9%) were of the anterior segment, 14 (36.8%) were of the posterior compartment, and 2 (5.3%) were combinations of the two. No apical failures were observed. The proportion of patients who returned to the office for scheduled visits decreased with increasing postoperative intervals as expected (Table IV) . At each postoperative interval, those patients with postoperative POP-Q data points (responders) and those without (nonresponders) were compared for objective and subjective differences. Table V summarizes the comparisons of objective data for responders and nonresponders. There were rare statistical differences between clinical and demographic characteristics of these groups. At 3 months, there were more smokers in the nonresponder group (18% vs 9%, P = .04). At 6 months, the responders were older (63 years vs 59 years, P = .006) than the nonresponders. A similar age dis- *PSI score = Sum of score of questions 1 to 11 (Table I) . †QOL score = Sum of score of questions 12 to 15 (Table I) .
crepancy was found at 1 year (responders = 63 years, nonresponders = 60 years, P = .03). At 2 years, body mass index was higher for the nonresponders (28 vs 25, P = .046). Our subjective assessments were collected via telephone interviews. A total of 206 patients (84.1% of the study population) were contacted by telephone between September and November 2001. The mean time between a patient's index sacral colpopexy and her telephone interview was 3.3 years (range, 0.8-6.9 years). All the patients contacted agreed to complete the validated PSI and QOL scale. Table VI summarizes the PSI and QOL scores for responders and nonresponders at all postoperative intervals. The only statistically significant difference was found at 6 months, when the PSI score was worse for responders than nonresponders (5.3 vs 7.0, P = .045).
Comment
To the best of our knowledge, this is the largest reported case series of abdominal sacral colpopexy procedures performed with synthetic mesh by using the POP-Q system as the objective outcome measure. Our data confirms several points from previous studies, namely, that sacral colpopexies are quite effective, that concomitant hysterectomy predisposes a patient to vaginal mesh erosion, 13, 14 and that objective failures predominantly involve the anterior compartment.
Attrition threatens the validity of even the most rigorous study design, the randomized clinical trial. However, randomization should control for selection bias as long as attrition rates do not differ in the study groups. In nonrandomized case series such as ours, selection bias threatens validity because healthier patients are more likely to keep their return appointments and thus have more complete data sets. This "healthy volunteer effect" explains the better outcomes reported in case series than seen in clinical practice. It is incumbent on researchers to control for selection bias when presenting outcome data in nonrandomized case series through statistical methods. We did so by comparing responders to nonresponders for objective and subjective measures, and there were no clinically significant differences between the two groups. Therefore, despite the postoperative attrition, we have no reason to question our conclusion that the vast majority of objective surgical failures (POP-Q stage ≥ II) after sacral colpopexy occur within the first 2 postoperative years. In other words, no selection bias or "healthy volunteer effect" seems to have affected this study.
For our POP-Q data point analysis, we chose a nonparametric repeated measures analysis (Wilcoxon test) because the exact date of surgical failure is unattainable in most cases. We believe that this statistical approach is more valid than life-table analysis using Kaplan Meier statistics.
Despite our attempts to control for selection bias, our study has several limitations. Ideally, POP-Q data points would have been assessed before and after surgery by an independent examiner (ie, not the patient's surgeon). This was not the case for our study. Also, the validated survey we used to assess subjective outcomes has not yet been correlated to degree of pelvic organ prolapse. Nevertheless, it was reassuring to find relatively low PSI and QOL scores (suggesting satisfaction) for the patients with and without objective follow-up because the fundamental goal of pelvic reconstructive surgery is to improve patients' quality of life. We look forward to the development of prolapse specific QOL instruments that are both externally and internally validated.
Our findings suggest that future prospective studies involving sacral colpopexy may be designed with only 1 or 2 years of follow-up, without significantly compromising their validity.
unique. As you stated, at each postoperative interval we compared those women with objective follow-up with those without objective follow-up to estimate the effects of selection bias. I agree that there are no established demographic risk factors for prolapse recurrence, but that does not mean such factors do not exist. Because there is limited information about sacral colpopexy failure, we could not possibly know risk factors for failure. So we were forced to analyze plausible demographic factors, which is what we did.
We then took this analysis a step further by contacting 85% of the total study group to assess their prolapse symptoms and quality of life. We cannot, as you suggested, correlate patients' subjective assessments with this POP-Q stage because the questionnaire was administered over the telephone. In other words, the POP-Q assessment was not carried out at the same time as the symptom questionnaire. The point of contacting all these women was to get an idea whether we had a large cohort of symptomatic failures out there who had not returned to our office. We are satisfied that no such cohort exists.
The subjective assessment tool we used has not been validated against the POP-Q, which I think brings up an interesting point. After prolapse surgery, do women care more about their symptoms or their POP-Q score? Who is to say that the POP-Q should not be validated against the symptom assessment tool we used?
Obviously, it would be ideal to have a complete set of 5-to 10-year subjective and objective follow-up for any study regarding prolapse surgery. Our conclusions do not contradict that fact. We are simply suggesting that 5 to 10 years of follow-up is not necessary to draw valid conclusions in future randomized clinical trials involving prolapse surgery. We hope these findings will prompt more researchers to carry out randomized clinical trials involving prolapse surgery.
